Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis
Open Access
- 30 July 2022
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 71, 116938
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Structure–activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttlingBioorganic & Medicinal Chemistry, 2013
- Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidaseTuberculosis, 2012
- MMPBSA.py: An Efficient Program for End-State Free Energy CalculationsJournal of Chemical Theory and Computation, 2012
- Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis AgentsJournal of Medicinal Chemistry, 2011
- The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosisJournal of Biological Chemistry, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- The Dual Function of the Mycobacterium tuberculosis FadD32 Required for Mycolic Acid BiosynthesisChemistry & Biology, 2009
- Pristinamycin-inducible gene regulation in mycobacteriaJournal of Biotechnology, 2009
- The Acyl-AMP Ligase FadD32 and AccD4-containing Acyl-CoA Carboxylase Are Required for the Synthesis of Mycolic Acids and Essential for Mycobacterial GrowthJournal of Biological Chemistry, 2005
- Relationship between the Structure and Antimycobacterial Activity of Substituted SalicylanilidesArchiv der Pharmazie, 2003